A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancer
Conclusion: The study did not demonstrate a significant benefit in administering resistant starch over and above normal diet to patients receiving pelvic radiotherapy. The reasons may be attributed to concurrent use of chemotherapy and decrease in intestinal probiotics. The use of digestible starch in the control arm may have contributed to lower incidence of the toxicity endpoints as well.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Balu Krishna Sasidharan Balamurugan Ramadass PN Viswanathan Prasanna Samuel Mahasampath Gowri Srinivasan Pugazhendhi Balakrishnan S Ramakrishna Source Type: research
More News: Bleeding | Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Chemotherapy | Diarrhoea | Diets | External Beam Therapy | Nutrition | Oral Cancer | Pain | Probiotics | Prostate Cancer | Radiation Therapy | Study | Toxicology